Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
NCT06585527
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Glioma, Malignant
Interventions
BIOLOGICAL:
TS-2021
Sponsor
Beijing Neurosurgical Institute